Global and United States Receptor Tyrosine Protein Kinase ERBB 3 Market Insights, Forecast to 2026

Global and United States Receptor Tyrosine Protein Kinase ERBB 3 Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
1.2 Market Segments
1.3 Key Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Type
1.4.2 BA-0702
1.4.3 CDX-3379
1.4.4 Elgemtumab
1.4.5 ETBX-031
1.4.6 Others
1.5 Market by Application
1.5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Application
1.5.2 Non-Small Cell Carcinoma
1.5.3 Solid Tumor
1.5.4 Melanoma
1.5.5 Colorectal Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, Estimates and Forecasts
2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2015-2026
2.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2015-2026
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Receptor Tyrosine Protein Kinase ERBB 3 Historical Market Size by Region (2015-2020)
2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2021-2026)
2.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2021-2026)
3 Global Receptor Tyrosine Protein Kinase ERBB 3 Competitor Landscape by Players
3.1 Global Top Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers
3.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (2015-2020)
3.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers (2015-2020)
3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers by Revenue
3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2015-2020)
3.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Receptor Tyrosine Protein Kinase ERBB 3 Revenue in 2019
3.2.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturers
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base Distribution, Product Types
3.4.1 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
3.4.3 Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type (2015-2020)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2015-2020)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2015-2020)
4.1.3 Receptor Tyrosine Protein Kinase ERBB 3 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Type (2021-2026)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2021-2026)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2021-2026)
4.2.3 Receptor Tyrosine Protein Kinase ERBB 3 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application (2015-2020)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2015-2020)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2015-2020)
5.1.3 Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2015-2020)
5.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Application (2021-2026)
5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2021-2026)
5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2021-2026)
5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
6.1.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales YoY Growth 2015-2026
6.1.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue YoY Growth 2015-2026
6.1.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Share in Global Market 2015-2026
6.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Players (International and Local Players)
6.2.1 United States Top Receptor Tyrosine Protein Kinase ERBB 3 Players by Sales (2015-2020)
6.2.2 United States Top Receptor Tyrosine Protein Kinase ERBB 3 Players by Revenue (2015-2020)
6.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Type (2015-2020)
6.3.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
6.3.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2015-2020)
6.3.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2015-2020)
6.4 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2021-2026)
6.4.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2021-2026)
6.4.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Type (2021-2026)
6.5 United States Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Application (2015-2020)
6.5.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
6.5.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2015-2020)
6.5.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2015-2020)
6.6 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2021-2026)
6.6.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2021-2026)
6.6.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Application (2021-2026)
7 North America
7.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
7.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
7.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2015-2020)
7.2.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
8.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
8.2.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
8.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
9.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
9.2.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2015-2020)
9.2.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
10.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
10.2.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
10.2.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
11.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
11.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Description and Business Overview
12.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 AVEO Pharmaceuticals, Inc.
12.2.1 AVEO Pharmaceuticals, Inc. Corporation Information
12.2.2 AVEO Pharmaceuticals, Inc. Description and Business Overview
12.2.3 AVEO Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.2.5 AVEO Pharmaceuticals, Inc. Recent Development
12.3 Etubics Corporation
12.3.1 Etubics Corporation Corporation Information
12.3.2 Etubics Corporation Description and Business Overview
12.3.3 Etubics Corporation Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.3.5 Etubics Corporation Recent Development
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
12.5 GamaMabs Pharma S.A.
12.5.1 GamaMabs Pharma S.A. Corporation Information
12.5.2 GamaMabs Pharma S.A. Description and Business Overview
12.5.3 GamaMabs Pharma S.A. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.5.5 GamaMabs Pharma S.A. Recent Development
12.6 GlaxoSmithKline Plc
12.6.1 GlaxoSmithKline Plc Corporation Information
12.6.2 GlaxoSmithKline Plc Description and Business Overview
12.6.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.6.5 GlaxoSmithKline Plc Recent Development
12.7 Hanmi Pharmaceuticals, Co. Ltd.
12.7.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
12.7.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
12.7.3 Hanmi Pharmaceuticals, Co. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.7.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
12.8 ImmunoGen, Inc.
12.8.1 ImmunoGen, Inc. Corporation Information
12.8.2 ImmunoGen, Inc. Description and Business Overview
12.8.3 ImmunoGen, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.8.5 ImmunoGen, Inc. Recent Development
12.9 Kolltan Pharmaceuticals, Inc.
12.9.1 Kolltan Pharmaceuticals, Inc. Corporation Information
12.9.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
12.9.3 Kolltan Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.9.5 Kolltan Pharmaceuticals, Inc. Recent Development
12.10 Merrimack Pharmaceuticals, Inc.
12.10.1 Merrimack Pharmaceuticals, Inc. Corporation Information
12.10.2 Merrimack Pharmaceuticals, Inc. Description and Business Overview
12.10.3 Merrimack Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.10.5 Merrimack Pharmaceuticals, Inc. Recent Development
12.11 AstraZeneca Plc
12.11.1 AstraZeneca Plc Corporation Information
12.11.2 AstraZeneca Plc Description and Business Overview
12.11.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.11.5 AstraZeneca Plc Recent Development
12.12 Novartis AG
12.12.1 Novartis AG Corporation Information
12.12.2 Novartis AG Description and Business Overview
12.12.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novartis AG Products Offered
12.12.5 Novartis AG Recent Development
12.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
12.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
12.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
12.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Products Offered
12.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
12.14 Sihuan Pharmaceutical Holdings Group Ltd.
12.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
12.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
12.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Products Offered
12.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
12.15 Sorrento Therapeutics, Inc.
12.15.1 Sorrento Therapeutics, Inc. Corporation Information
12.15.2 Sorrento Therapeutics, Inc. Description and Business Overview
12.15.3 Sorrento Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sorrento Therapeutics, Inc. Products Offered
12.15.5 Sorrento Therapeutics, Inc. Recent Development
12.16 Symphogen A/S
12.16.1 Symphogen A/S Corporation Information
12.16.2 Symphogen A/S Description and Business Overview
12.16.3 Symphogen A/S Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Symphogen A/S Products Offered
12.16.5 Symphogen A/S Recent Development
12.17 Takis S.r.l.
12.17.1 Takis S.r.l. Corporation Information
12.17.2 Takis S.r.l. Description and Business Overview
12.17.3 Takis S.r.l. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Takis S.r.l. Products Offered
12.17.5 Takis S.r.l. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Receptor Tyrosine Protein Kinase ERBB 3 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Receptor Tyrosine Protein Kinase ERBB 3 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Receptor Tyrosine Protein Kinase ERBB 3 Market Segments
Table 2. Ranking of Global Top Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BA-0702
Table 5. Major Manufacturers of CDX-3379
Table 6. Major Manufacturers of Elgemtumab
Table 7. Major Manufacturers of ETBX-031
Table 8. Major Manufacturers of Others
Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Regions (2015-2020)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers (2015-2020)
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2019)
Table 19. Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Price (2015-2020) (USD/Pcs)
Table 22. Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 24. Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2015-2020) (K Pcs)
Table 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2015-2020)
Table 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2015-2020)
Table 30. Receptor Tyrosine Protein Kinase ERBB 3 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2021-2026)
Table 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2015-2020) (K Pcs)
Table 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2015-2020)
Table 34. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2021-2026)
Table 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) of Key Companies (2015-2020)
Table 39. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Company (2015-2020)
Table 40. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2015-2020)
Table 43. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2015-2020)
Table 45. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2021-2026)
Table 46. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2021-2026)
Table 47. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2021-2026)
Table 49. United States Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2021-2026)
Table 50. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 51. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2015-2020)
Table 52. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2021-2026)
Table 54. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2021-2026)
Table 55. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2021-2026)
Table 57. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2015-2020) (K Pcs)
Table 58. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2015-2020)
Table 59. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2015-2020)
Table 61. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2015-2020)
Table 63. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2015-2020)
Table 69. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2015-2020)
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Business Overview
Table 79. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 81. AstraZeneca Plc Recent Development
Table 82. AVEO Pharmaceuticals, Inc. Corporation Information
Table 83. AVEO Pharmaceuticals, Inc. Description and Business Overview
Table 84. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. AVEO Pharmaceuticals, Inc. Product
Table 86. AVEO Pharmaceuticals, Inc. Recent Development
Table 87. Etubics Corporation Corporation Information
Table 88. Etubics Corporation Description and Business Overview
Table 89. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Etubics Corporation Product
Table 91. Etubics Corporation Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Corporation Information
Table 93. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 94. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Ltd. Product
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. GamaMabs Pharma S.A. Corporation Information
Table 98. GamaMabs Pharma S.A. Description and Business Overview
Table 99. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. GamaMabs Pharma S.A. Product
Table 101. GamaMabs Pharma S.A. Recent Development
Table 102. GlaxoSmithKline Plc Corporation Information
Table 103. GlaxoSmithKline Plc Description and Business Overview
Table 104. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. GlaxoSmithKline Plc Product
Table 106. GlaxoSmithKline Plc Recent Development
Table 107. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 108. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
Table 109. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Hanmi Pharmaceuticals, Co. Ltd. Product
Table 111. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 112. ImmunoGen, Inc. Corporation Information
Table 113. ImmunoGen, Inc. Description and Business Overview
Table 114. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. ImmunoGen, Inc. Product
Table 116. ImmunoGen, Inc. Recent Development
Table 117. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 118. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 119. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Kolltan Pharmaceuticals, Inc. Product
Table 121. Kolltan Pharmaceuticals, Inc. Recent Development
Table 122. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 123. Merrimack Pharmaceuticals, Inc. Description and Business Overview
Table 124. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Merrimack Pharmaceuticals, Inc. Product
Table 126. Merrimack Pharmaceuticals, Inc. Recent Development
Table 127. Merus B.V. Corporation Information
Table 128. Merus B.V. Description and Business Overview
Table 129. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Merus B.V. Product
Table 131. Merus B.V. Recent Development
Table 132. Novartis AG Corporation Information
Table 133. Novartis AG Description and Business Overview
Table 134. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Novartis AG Product
Table 136. Novartis AG Recent Development
Table 137. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 138. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 139. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product
Table 141. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
Table 142. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
Table 143. Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
Table 144. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Sihuan Pharmaceutical Holdings Group Ltd. Product
Table 146. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
Table 147. Sorrento Therapeutics, Inc. Corporation Information
Table 148. Sorrento Therapeutics, Inc. Description and Business Overview
Table 149. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Sorrento Therapeutics, Inc. Product
Table 151. Sorrento Therapeutics, Inc. Recent Development
Table 152. Symphogen A/S Corporation Information
Table 153. Symphogen A/S Description and Business Overview
Table 154. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. Symphogen A/S Product
Table 156. Symphogen A/S Recent Development
Table 157. Takis S.r.l. Corporation Information
Table 158. Takis S.r.l. Description and Business Overview
Table 159. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 160. Takis S.r.l. Product
Table 161. Takis S.r.l. Recent Development
Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 163. Key Challenges
Table 164. Market Risks
Table 165. Main Points Interviewed from Key Receptor Tyrosine Protein Kinase ERBB 3 Players
Table 166. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
Table 167. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2020 & 2026
Figure 3. BA-0702 Product Picture
Figure 4. CDX-3379 Product Picture
Figure 5. Elgemtumab Product Picture
Figure 6. ETBX-031 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2020 & 2026
Figure 9. Non-Small Cell Carcinoma
Figure 10. Solid Tumor
Figure 11. Melanoma
Figure 12. Colorectal Cancer
Figure 13. Others
Figure 14. Receptor Tyrosine Protein Kinase ERBB 3 Report Years Considered
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2015-2026 (US$ Million)
Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2015-2026 (K Pcs)
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2015

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs